Stromacel Inc (OTC Pink - No Information:PROT)

Data as of Sep 15
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Proteonomix, Inc. is a biotechnology company engaged in the discovery and development of stem cell therapeutic and cosmeceutical products. It is developing pre clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. The company's discoveries involve non embryonic stem cell treatments. It operates through the following segments: the sperm bank division, the stem-cell division, the skin care products division, PRTMI, Thor and StromaCel. Proteonomix was founded by Michael Moshe Cohen on June 26, 1995 and is headquartered in Hawthorne, NJ.

Contact Information

Proteonomix, Inc.
140 East Ridgewood Avenue
Paramus New Jersey 07652
P:(973) 949-4195
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Michael Moshe CohenChairman, President, CEO, COO, CAO & Controller
Thomas Peter MonahanChief Financial Officer
Steven Mark ByleDirector & Chief Technology Officer
Roger L. FidlerTreasurer, Director & General Counsel
Jason B. IsaacsSecretary

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.